Jump to content
  • Sign Up
Scott Adams

Biolinerx Reports Results From Phase 1/2 Study For Celiac Treatment - Pharmaceutical Business Review

Rate this topic

Recommended Posts

BioLineRx reports results from Phase 1/2 study for celiac treatment

Pharmaceutical Business Review

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today unblinded results from its Phase 1/2 study for BL-7010, a novel polymer for the treatment of ...

View the full article

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...